insights_auto
Bakit tumaas ang ALKS 2.98%?
Tingnan ang Higit pang Detalyechevron_right
ALKS:NASDAQ
Alkermes Plc
$41.75
arrow_upward
+2.98%(+1.21) 1D
$41.75
0.00% (0.00)
bedtimePagkalipas ng oras ng trabaho
Sarado: Okt 2, 4:00:01 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa ALKS...
Buksan
$41.03
Mataas
$41.96
Mababa
$40.32
Mkt. cap
7.00B
Avg. na dami
1.98M
Dami
2.42M
P/E ratio
108.48
Mataas nang 52-wk
$55.67
Mababa nang 52-wk
$27.00
EPS
$0.38
Beta
0.29
Mga natitirang share
167.76M
Bilang ng mga empleyado
2K
Buksan
$41.03
Mataas
$41.96
Mababa
$40.32
Mkt. cap
7.00B
Avg. na dami
1.98M
Dami
2.42M
P/E ratio
108.48
Mataas nang 52-wk
$55.67
Mababa nang 52-wk
$27.00
EPS
$0.38
Beta
0.29
Mga natitirang share
167.76M
Bilang ng mga empleyado
2K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Investing.com Nigeria
·
5 oras ang nakalipas
Form 4 Alkermes plc. For: 3 October By Investing.com
Yahoo Finance
·
3 araw ang nakalipas
LQDA versus ALKS: Which Biotech Stock Is the Better Buy Now?
Profile
Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall. In September 2011 Alkermes, Inc. merged with Elan Drug Technologies, the former drug formulation and manufacturing division of Élan Corporation, plc. The company is headquartered in Dublin, and has an R&D center in Waltham, Massachusetts, and a manufacturing facility in Wilmington, Ohio. Wikipedia
Tungkol sa Alkermes Plc
CEORichard F. Pops | Richard F. Pops
Mga Empleyado2.05K
Itinatag1987
Headquarters-
Sektor-
Websitealkermes.com